Conference Proceedings

Clinical Activity of LOXO-292, a Highly Selective RET Inhibitor, in Patients with RET Fusion plus Non-Small Cell Lung Cancer

G Oxnard, V Subbiah, K Park, T Bauer, L Wirth, V Velcheti, M Shah, B Besse, V Boni, K Reckamp, H Loong, L Bazhenova, B Solomon, D Tan, J Patel, M Johnson, A Gazzah, T Mok, S Smith, B Tuch Show all

Journal of Thoracic Oncology | ELSEVIER SCIENCE INC | Published : 2018